(Q24201392)

2

0 references

Xin-Feng Guo

3

0 references

Yifan Wu

4

0 references

Xusheng Liu

5

0 references

Chuan Zou

6

0 references

Lei Zhang

7

0 references

Qianchun Yang

8

0 references

Yuan Xu

9

0 references

Weizhong Ma

Cochrane Database of Systematic Reviews

10

0 references

publication date

28 February 2013

0 references

published in

0 references

cites work

Metabolic effects of two low protein diets in chronic kidney disease stage 4-5--a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010350

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010350

Treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010350

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010350

Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010350

Chronic kidney disease-mineral-bone disorder: a new paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010350

Mineral and bone disease pattern in elderly haemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010350

Osteo-renal regulation of systemic phosphate metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010350

The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010350

Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010350

Phosphate restriction in diet therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010350

Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010350

The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010350

Effects of dietary phosphate restriction in children with chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010350

7 January 2021

inferred from DOI database lookup

Weighing the evidence for treatment of chronic kidney disease mineral and bone disorder

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010350

7 January 2021

inferred from DOI database lookup

Comparison of a vegetable-based (soya) and an animal-based low-protein diet in predialysis chronic renal failure patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010350

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1002/14651858.CD010350

0 references

Fatcat ID

release_dlb4yujv55egtewahwcbny3e5a

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dlb4yujv55egtewahwcbny3e5a

24 November 2022